SRx Health Solutions announced on March 25 2026 that it will shift its decentralized‑finance (DeFi) portfolio hedging to gold and reduce exposure to emerging‑market assets, a move that follows the company’s December 2025 definitive merger agreement with EMJ Crypto Technologies (EMJX).
The change comes after SRx’s Q1 FY2026 results, which showed net sales of $2.8 million and a net loss of $8.6 million, and after the company’s $18 million allocation to Bitcoin and Ethereum. By moving to gold, SRx aims to dampen volatility in its crypto treasury while preserving upside potential.
The announcement also reduces the company’s exposure to emerging‑market assets, which had been part of its broader risk‑management framework. The shift reflects a preference for more liquid instruments and a response to the high‑yield but higher‑risk profile of emerging‑market holdings.
Management noted that the hedging adjustment is part of the broader strategy to transform SRx from a pet‑food business into a digital‑asset treasury platform. Director Michael Young said, "We are looking forward to the closing of EMJX in the near future," underscoring confidence in the merger’s value creation.
The move is the first publicly disclosed change to the EMJX hedging strategy since the merger was announced in December 2025. It signals a tightening of risk controls as the company prepares to integrate EMJX’s "Gen2" quantitative, AI‑driven treasury model.
The change is expected to lower the overall risk profile of SRx’s crypto holdings and provide a more predictable return stream for investors, aligning with the company’s goal of stabilizing its capital base amid the volatile crypto market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.